* Program subject to change
Kwang Hyub Han, MD, PhD
National Evidence-based Healthcare Collaborating Agency, Seoul, Korea, Republic of (South)
Shawn Vasoo, MBBS, MRCP, D (ABIM) (Infectious Diseases)
National Centre for Infectious Diseases, Tan Tock Seng Hospital, -, Singapore
Wang-jun Lee, MD, PhD
Myongii Hospital, Seoul, Korea, Republic of (South)
Kenji Shibuya, MD, DrPH
King’s College, London, United Kingdom
Fan Wu, MD, PhD
Shanghai Medical College of Fudan University, Shanghai, China
Elina Hypponen, PhD, MPH, MSc
Australian Centre for Precision Health, University of South Australia Cancer Research Institute, Adelaide, Australia
Yeul Hong Kim, MD, PhD
Korea University College of Medicine, K-MASTER Cancer Precision Medicine Diagnosis and Treatment Enterprise, Seoul, Korea, Republic of (South)
Kazuhiko Yamamoto, MD, PhD
RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
Teo Yik Ying, PhD
National University of Singapore, Singapore, Singapore
Xiaotian Zhang, MD, PhD
Peking University Cancer Hospital & School of Oncology, Beijing, China
Diane Munch, MA
Pfizer, Inc., New York, NY, USA
Jeonghoon Ahn, PhD
Ewha Womans University, Seoul, Korea, Republic of (South)
Sarah Fitt, BPharm
Pharmaceutical Management Agency (PHARMAC), Wellington, New Zealand
Shanlian Hu, MSc, MD
School of Public Health, Fudan University, Shanghai, China
Netnapis Suchonwanich
Health Intervention and Technology Assessment Program (HITAP), Bangkok, Thailand